TrialClinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology2019

Efficacy and safety of birch pollen allergoid subcutaneous immunotherapy: A 2-year double-blind, placebo-controlled, randomized trial plus 1-year open-label extension.

Margitta Worm et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.